Phosphoric Acid

Phosphoric Acid

SCHEMBL391749

O=P(O)(O)O.O=P([O-])(O)O.O=P([O-])(O)O.[Na+].[Na+]

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRB1ADRB2ADRB3CYP11B1DPP4FGFR1FGFR2FGFR3FGFR4HRH1JAK1JAK2JAK3KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITNAOPRD1OPRK1OPRM1PPDGFRBPIK3CDSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASMOTYK2polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC34A1 Q06495 1/20 0.73
KDM4E B2RXH2 2/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 1/20 0.47
LMNA P02545 2/20 0.47
CA2 P00918 1/20 0.39
CA1 P00915 2/20 0.37
CA4 P22748 2/20 0.37
CA5A P35218 2/20 0.37
CA5B Q9Y2D0 2/20 0.37
MMP2 P08253 1/20 0.33
THRB P10828 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
FDPS P14324 1/20 0.33
BLM P54132 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL9256279 1.00 SLC34A1 (0.73) SLC34A1KDM4ECYP2C19KMT2ALMNA
Phosphoric Acid SCHEMBL935357 1.00 SLC34A1 (0.73) SLC34A1KDM4ECYP2C19KMT2ALMNA
Phosphoric Acid SCHEMBL7762283 1.00 SLC34A1 (0.73) SLC34A1KDM4ECYP2C19KMT2ALMNA
Phosphoric Acid SCHEMBL4754839 1.00 SLC34A1 (0.73) SLC34A1KDM4ECYP2C19KMT2ALMNA
Phosphoric Acid SCHEMBL4619306 1.00 SLC34A1 (0.73) SLC34A1KDM4ECYP2C19KMT2ALMNA
Phosphoric Acid SCHEMBL5157618 1.00 SLC34A1 (0.73) SLC34A1KDM4ECYP2C19KMT2ALMNA
Phosphoric Acid SCHEMBL28240907 1.00 SLC34A1 (0.73) SLC34A1KDM4ECYP2C19KMT2ALMNA
Phosphoric Acid SCHEMBL10692716 1.00 SLC34A1 (0.73) SLC34A1KDM4ECYP2C19KMT2ALMNA
Phosphoric Acid SCHEMBL7765982 1.00 SLC34A1 (0.73) SLC34A1KDM4ECYP2C19KMT2ALMNA
Phosphoric Acid SCHEMBL3400141 0.95 SLC34A1 (0.67) SLC34A1KDM4ECYP2C19KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023198737-A1 OPHTHALMOLOGICAL VISCOELASTIC COMPOSITION HYALTECH LTD. (GB) 2023-10-19 WO claimed
EP-2181690-B1 Perfume composition with reduced alcohol content COTY INC (US) 2011-11-09 EP claimed
EP-2181690-A1 Perfume composition with reduced alcohol content Coty Inc. (US) 2010-05-05 EP claimed
EP-0936865-B1 STABLE AQUEOUS FORMULATION OF 3-(N-BUTYLACETAMINO)-PROPIONIC ACID ETHYL ESTER MERCK PATENT GMBH (DE) 2002-12-18 EP claimed
US-6306905-B1 INSECT REPELLANTS AND BUFFER SYSTEM MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2001-10-23 US claimed
US-11911712-B2 Method for preparing aqueous solutions of a defined pH FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (GB) 2024-02-27 US disclosed
WO-2023198737-A1 OPHTHALMOLOGICAL VISCOELASTIC COMPOSITION HYALTECH LTD. (GB) 2023-10-19 WO disclosed
CN-113151377-A Enzymatic preparation method for preparing glucosamine from glucose and enzyme application 江苏澳新生物工程有限公司 2021-07-23 CN disclosed
CN-112522225-A Method for modifying uricase by polyethylene glycol 鲁南制药集团股份有限公司 2021-03-19 CN disclosed
EP-3692363-A1 METHOD FOR PREPARING AQUEOUS SOLUTIONS OF A DEFINED PH Fujifilm Diosynth Biotechnologies UK Limited (GB) 2020-08-12 EP disclosed
CN-109370998-B Omega-transaminase mutant I215F with improved catalytic efficiency 江南大学 2020-08-04 CN disclosed
CN-109456952-B Omega-transaminase mutant capable of catalyzing sitafloxacin five-membered ring key intermediate 江南大学 2020-08-04 CN disclosed
US-5244471-A Monoazo dyes CASSELLA AG (DE) 1993-09-14 US disclosed
EP-0182558-B1 NON-RIGID VINYL CHLORIDE POLYMER RESIN COMPOSITION MITSUBISHI RAYON CO., LTD. (JP) 1991-03-13 EP disclosed
EP-0367198-A2 Lubricant for thermoplastic resin and thermoplastic resin composition comprising said lubricant MITSUBISHI RAYON CO., LTD. (JP) 1990-05-09 EP disclosed
US-4877522-A Liquid supply apparatus TOSHO CORPORATION (JP) 1989-10-31 US disclosed
US-4705524-A Mixtures of water-soluble fiber-reactive dyes and use thereof for dyeing: dioxazine and disazo dyes HOECHST AKTIENGESELLSCHAFT (DE) 1987-11-10 US disclosed
EP-0237045-A2 DNA encoding flagellin and vector having the same SHIONOGI & CO., LTD. (JP) 1987-09-16 EP disclosed
US-4663382-A WEATHERABILITY, IMPACT STRENGTH MITSUBISHI RAYON COMPANY, LTD. (JP) 1987-05-05 US disclosed
EP-0182558-A2 Non-rigid vinyl chloride polymer resin composition MITSUBISHI RAYON CO., LTD. (JP) 1986-05-28 EP disclosed